SUBSCRIBE
SUBSCRIBE
Pharm Country

US FDA Probes Risks of HIV, Prostate, Other Drugs; Abbott Laboratories’ Kaletra, GlaxoSmithKline’s Avodart on List

May 4, 2010 | 
1 min read

Reuters -- U.S. regulators are investigating potential risks from Abbott Laboratories Inc’s (ABT.N) HIV drug Kaletra, GlaxoSmithKline Plc’s (GSK.L) prostate drug Avodart and other medicines.

GlaxoSmithKline Food and Drug Administration (FDA) Abbott Laboratories
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Mother covering her face, experiencing depression symptoms
Drug Development
Novo-Backed Reunion Raises $103M Series A Financing for Psychedelic Trial
May 3, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: BMS sign on a building in San Diego, California/iStock, JHVEPhoto
Business
BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases
April 29, 2024
 · 
2 min read
 · 
Tyler Patchen